Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $30.2 million.

  • Lifecore Biomedical, Inc. \De\'s Total Current Liabilities fell 2236.57% to $30.2 million in Q2 2025 from the same period last year, while for May 2025 it was $30.2 million, marking a year-over-year decrease of 2236.57%. This contributed to the annual value of $30.2 million for FY2025, which is 2236.57% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Total Current Liabilities amounted to $30.2 million in Q2 2025, which was down 2236.57% from $31.1 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Total Current Liabilities registered a high of $195.6 million during Q4 2022, and its lowest value of $30.2 million during Q2 2025.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Total Current Liabilities had a median value of $40.4 million in 2023 and averaged $81.1 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Total Current Liabilities surged by 7337.02% in 2022 and then plummeted by 8018.63% in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Total Current Liabilities (Quarter) stood at $122.4 million in 2021, then surged by 59.83% to $195.6 million in 2022, then tumbled by 79.42% to $40.3 million in 2023, then dropped by 12.33% to $35.3 million in 2024, then dropped by 14.49% to $30.2 million in 2025.
  • Its Total Current Liabilities stands at $30.2 million for Q2 2025, versus $31.1 million for Q1 2025 and $35.3 million for Q4 2024.